PL2281875T3 - Wyizolowane komórki macierzyste wątroby - Google Patents

Wyizolowane komórki macierzyste wątroby

Info

Publication number
PL2281875T3
PL2281875T3 PL10192665T PL10192665T PL2281875T3 PL 2281875 T3 PL2281875 T3 PL 2281875T3 PL 10192665 T PL10192665 T PL 10192665T PL 10192665 T PL10192665 T PL 10192665T PL 2281875 T3 PL2281875 T3 PL 2281875T3
Authority
PL
Poland
Prior art keywords
stem cells
liver
relates
present
progenitor stem
Prior art date
Application number
PL10192665T
Other languages
English (en)
Inventor
Etienne Sokal
Mustapha Najimi
Original Assignee
Université Catholique de Louvain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37775557&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2281875(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Université Catholique de Louvain filed Critical Université Catholique de Louvain
Publication of PL2281875T3 publication Critical patent/PL2281875T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/067—Hepatocytes
    • C12N5/0672—Stem cells; Progenitor cells; Precursor cells; Oval cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5067—Liver cells
PL10192665T 2005-12-21 2006-12-14 Wyizolowane komórki macierzyste wątroby PL2281875T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05447286 2005-12-21
EP2006010014 2006-10-17
EP10192665.7A EP2281875B1 (en) 2005-12-21 2006-12-14 Isolated liver stem cells
EP06819033.9A EP1969118B2 (en) 2005-12-21 2006-12-14 Isolated liver stem cells

Publications (1)

Publication Number Publication Date
PL2281875T3 true PL2281875T3 (pl) 2018-08-31

Family

ID=37775557

Family Applications (2)

Application Number Title Priority Date Filing Date
PL06819033T PL1969118T5 (pl) 2005-12-21 2006-12-14 Wyizolowane komórki macierzyste wątroby
PL10192665T PL2281875T3 (pl) 2005-12-21 2006-12-14 Wyizolowane komórki macierzyste wątroby

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL06819033T PL1969118T5 (pl) 2005-12-21 2006-12-14 Wyizolowane komórki macierzyste wątroby

Country Status (13)

Country Link
US (5) US8673635B2 (pl)
EP (2) EP1969118B2 (pl)
JP (1) JP5250423B2 (pl)
CN (1) CN103989710B (pl)
AT (1) ATE498005T1 (pl)
AU (1) AU2006328988B2 (pl)
CA (1) CA2634510C (pl)
DE (1) DE602006020071D1 (pl)
DK (2) DK2281875T3 (pl)
ES (1) ES2672205T3 (pl)
PL (2) PL1969118T5 (pl)
PT (1) PT2281875T (pl)
WO (1) WO2007071339A1 (pl)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2672205T3 (es) * 2005-12-21 2018-06-13 Université Catholique de Louvain Células madre hepáticas aisladas
EP2179034A1 (en) * 2007-07-20 2010-04-28 Cellartis AB A novel population of hepatocytes derived via definitive endoderm (de-hep) from human blastocysts stem cells
WO2010090513A2 (en) 2009-02-03 2010-08-12 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising said stem cells.
EP2412800A1 (en) 2010-07-29 2012-02-01 Koninklijke Nederlandse Akademie van Wetenschappen Liver organoid, uses thereof and culture method for obtaining them
US9752124B2 (en) 2009-02-03 2017-09-05 Koninklijke Nederlandse Akademie Van Wetenschappen Culture medium for epithelial stem cells and organoids comprising the stem cells
US20130071365A1 (en) * 2010-02-16 2013-03-21 Kyushu University, National University Corporation Induced hepatocytes
WO2012005690A1 (en) * 2010-07-07 2012-01-12 Massachusetts Institute Of Technology Methods of reconstituting human hepatocytes and human hematopoietic cells in non-human mammals
JP6000950B2 (ja) * 2010-08-12 2016-10-05 アーベーアーゲー フェアヴァルトゥングス ゲーエムベーハーＡｂａｇ Ｖｅｒｗａｌｔｕｎｇｓ Ｇｍｂｈ 肝細胞の特徴を有する細胞を産生するための方法並びに同方法により産生された細胞及びその使用
US20130302291A1 (en) 2011-01-25 2013-11-14 Universite Catholique De Louvain Compositions and methods for cell transplantation
WO2013110354A1 (en) 2012-01-25 2013-08-01 Université Catholique de Louvain Compositions and methods for cell transplantation
JP6095272B2 (ja) * 2011-03-25 2017-03-15 国立大学法人京都大学 上皮系体性幹細胞の製造方法
EP2554176B1 (en) 2011-08-04 2016-07-27 ETHIANUM Betriebsgesellschaft mbH & Co. KG Means for liver regeneration
WO2013047720A1 (ja) * 2011-09-30 2013-04-04 公立大学法人横浜市立大学 肝細胞の分化誘導方法、ヒト化肝臓キメラ非ヒト動物の作製方法
US20140162355A1 (en) * 2012-12-07 2014-06-12 Antria, Inc. Formulations Containing and Kit for Using Adipose-Derived Stem Cells and Use Thereof
ES2759228T3 (es) 2013-07-05 2020-05-08 Univ Catholique Louvain Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado
US10172889B2 (en) * 2013-08-28 2019-01-08 Promethera Biosciences S.A./N.V. Method for producing adult liver progenitor cells
WO2016001839A1 (en) * 2014-06-30 2016-01-07 Stempeutics Research Pvt. Ltd. Management of liver disease using pooled mesenchymal stromal cells
JP2017530697A (ja) * 2014-08-28 2017-10-19 プロメセラ バイオサイエンシーズ エス．アー．／エンヌ．フェー． 成体肝前駆細胞を作製する方法
WO2016086132A1 (en) * 2014-11-26 2016-06-02 Accelerated Biosciences Corp. Induced hepatocytes and uses thereof
FR3035407B1 (fr) 2015-04-23 2022-06-17 Francais Du Sang Ets Procede de conservation de cellules, tissus ou organes en hypothermie
WO2016183231A1 (en) 2015-05-12 2016-11-17 Baker Group, LLP Method and system for a bioartificial organ
US10774312B2 (en) * 2015-05-14 2020-09-15 Advanced Cell Technology And Engineering Ltd. Method for producing frozen mesenchymal cells and method for producing implantable therapeutic member
CN108431209B (zh) * 2015-06-12 2023-02-10 新加坡科技研究局 肝脏干细胞的衍生和成熟肝细胞类型及其用途
US10287543B2 (en) * 2015-11-19 2019-05-14 Miltenyi Biotec, Gmbh Process and device for isolating cells from biological tissue
JP7063624B2 (ja) * 2016-01-08 2022-05-09 エヴィア ライフ サイエンシズ インコーポレイテッド 低分子化合物による成熟肝細胞からの肝幹／前駆細胞の作製方法
JP6704617B2 (ja) * 2016-01-29 2020-06-03 北海道公立大学法人 札幌医科大学 小型肝細胞の継代培養方法
EP3414319A4 (en) 2016-02-10 2019-08-28 Wake Forest University Health Sciences HEPATIC FIBROSIS MODEL SYSTEM AND METHOD FOR MANUFACTURING AND USING SAME
MA45274A (fr) * 2016-03-02 2019-01-09 Univ Catholique Louvain Préparations améliorées de cellules progénitrices hépatiques adultes
JP2019516391A (ja) * 2016-05-24 2019-06-20 リ, アルバートLI, Albert 新規な細胞培養方法、細胞培養システム、およびそれらの使用
US11976302B2 (en) 2017-05-06 2024-05-07 Upside Foods, Inc. Compositions and methods for increasing the culture density of a cellular biomass within a cultivation infrastructure
CA3064352A1 (en) 2017-05-24 2018-11-29 Thoeris Gmbh Use of glutamine synthetase for treating hyperammonemia
WO2019014652A1 (en) * 2017-07-13 2019-01-17 Memphis Meats, Inc. COMPOSITIONS AND METHODS FOR INCREASING THE EFFICACY OF CELL CULTURES USED IN FOOD PRODUCTION
US11407979B2 (en) 2017-09-01 2022-08-09 Colorado State University Research Foundation Intermittent starvation techniques to prolong functional lifetime of liver cells in culture
US20210015844A1 (en) 2018-03-14 2021-01-21 Beacon Medcare (Hk) Limited Composition for purification of biofluids
CN108823146A (zh) * 2018-06-22 2018-11-16 安徽 一种肝脏干细胞制备和提取方法
TW202035682A (zh) 2018-12-14 2020-10-01 比利時商普羅米修亞生物科技股份有限公司 表現hla-g之肝先驅細胞及取得包含該等細胞之此等細胞組成物之方法與其用途
TW202043463A (zh) 2018-12-14 2020-12-01 比利時商普羅米修亞生物科技股份有限公司 包含表現hla-e之肝先驅細胞之細胞組成物
CN109735485B (zh) * 2019-01-29 2021-04-16 深圳市拓普生物科技有限公司 人源化肝脏动物模型及其构建方法和应用
EP3947645A1 (en) 2019-03-26 2022-02-09 Promethera Therapeutics Sa Adult liver progenitor cells for treating non-alcoholic fatty liver disease
SG11202110476YA (en) 2019-03-26 2021-10-28 Promethera Therapeutics Sa Adult liver progenitor cells for treating acute-on-chronic liver failure
JP7284985B2 (ja) * 2019-03-29 2023-06-01 国立大学法人 長崎大学 肝前駆細胞を含む細胞集団を製造する方法
EP3963049A1 (en) 2019-04-30 2022-03-09 Promethera Therapeutics Sa Preparation of human allogeneic liver-derived progenitor cells
JP2022530620A (ja) 2019-04-30 2022-06-30 プロメセラ セラピューティクス エスエイ ヒト同種肝臓由来前駆細胞の調製
WO2021021612A1 (en) * 2019-07-26 2021-02-04 Ambys Medicines, Inc. Methods and compositions for producing hepatocytes
KR20220081368A (ko) 2019-10-09 2022-06-15 셀라온 에스에이 혈관 과투과성을 특징으로 하는 장애에서 간 전구세포 또는 줄기세포, 이의 용해물 및/또는 조건화 배지의 사용
JP2023516484A (ja) 2020-03-11 2023-04-19 ビット バイオ リミテッド 肝細胞作製方法
EP3881853A1 (en) 2020-03-20 2021-09-22 Promethera Therapeutics Sa Human allogeneic liver-derived progenitor cells for use in the treatment of inflammatory and infectious lung diseases and systemic inflammation
EP3929280A1 (en) 2020-06-26 2021-12-29 Medizinische Hochschule Hannover Process for producing liver cells
WO2023180122A1 (en) 2022-03-24 2023-09-28 Université Catholique de Louvain Use of human allogenic liver-derived progenitor cells for treating and/or preventing cellular senescence

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2917998B2 (ja) * 1988-02-05 1999-07-12 ホワイトヘッド・インスティチュート・フォー・バイオメディカル・リサーチ 修飾された肝細胞およびその用途
US6069005A (en) † 1991-08-07 2000-05-30 Albert Einstein College Of Medicine Of Yeshwa University Hapatoblasts and method of isolating same
WO1994008598A1 (en) 1992-10-09 1994-04-28 Advanced Tissue Sciences, Inc. Liver reserve cells
US5869243A (en) 1996-03-05 1999-02-09 Rhode Island Hospital Immortalized hepatocytes
DE69739497D1 (de) 1996-10-01 2009-08-27 Geron Corp Menschlische Telomerase katalytische Untereinheit
US6774120B1 (en) 1999-06-01 2004-08-10 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
US8778899B2 (en) * 1999-06-01 2014-07-15 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
EP1252293B1 (en) * 2000-01-19 2012-10-03 University Of North Carolina At Chapel Hill Liver tissue source
DE60221987T2 (de) * 2001-06-22 2008-05-15 Stemcells, Inc., Palo Alto Le-zellen (liver engrafting cells), assays und verwendungen davon
US6617152B2 (en) 2001-09-04 2003-09-09 Corning Inc Method for creating a cell growth surface on a polymeric substrate
WO2003033697A1 (en) * 2001-10-18 2003-04-24 Ixion Biotechnology, Inc. Conversion of liver stem and progenitor cells to pancreatic functional cells
EP1624898A1 (en) 2003-05-12 2006-02-15 Sarah Ferber Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues
US20050074876A1 (en) * 2003-10-03 2005-04-07 Inserm Bipotential liver cell lines from wild-type mammalian liver tissue
WO2005035738A1 (en) * 2003-10-07 2005-04-21 Biomaster Inc. Cell differentiation of adipose-derived precursor cells
WO2006126219A1 (en) * 2005-05-26 2006-11-30 Fresenius Medical Care Deutschland G.M.B.H. Liver progenitor cells
ES2672205T3 (es) * 2005-12-21 2018-06-13 Université Catholique de Louvain Células madre hepáticas aisladas

Also Published As

Publication number Publication date
US8778607B2 (en) 2014-07-15
US9775863B2 (en) 2017-10-03
JP5250423B2 (ja) 2013-07-31
WO2007071339A1 (en) 2007-06-28
JP2009520474A (ja) 2009-05-28
PL1969118T3 (pl) 2011-07-29
PL1969118T5 (pl) 2015-06-30
DK2281875T3 (en) 2018-06-06
PT2281875T (pt) 2018-06-11
US20170354687A1 (en) 2017-12-14
EP2281875A1 (en) 2011-02-09
CN103989710B (zh) 2019-11-15
US20140127676A1 (en) 2014-05-08
US20140286917A1 (en) 2014-09-25
ATE498005T1 (de) 2011-02-15
ES2672205T3 (es) 2018-06-13
CA2634510C (en) 2018-01-09
DE602006020071D1 (de) 2011-03-24
US9107910B2 (en) 2015-08-18
EP1969118A1 (en) 2008-09-17
US9931360B2 (en) 2018-04-03
AU2006328988A1 (en) 2007-06-28
US20150306147A1 (en) 2015-10-29
US20080311094A1 (en) 2008-12-18
DK1969118T4 (en) 2014-12-15
AU2006328988B2 (en) 2012-08-02
CN103989710A (zh) 2014-08-20
EP2281875B1 (en) 2018-03-21
DK1969118T3 (da) 2011-05-16
EP1969118B2 (en) 2014-09-10
EP1969118B1 (en) 2011-02-09
US8673635B2 (en) 2014-03-18
CA2634510A1 (en) 2007-06-28

Similar Documents

Publication Publication Date Title
PL1969118T3 (pl) Wyizolowane komórki macierzyste wątroby
Thorgeirsson et al. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence
Sakaida et al. Development of cell therapy using autologous bone marrow cells for liver cirrhosis
WO2007100692A3 (en) Method of generating human retinal progenitors from embryonic stem cells
PL1888742T3 (pl) Komórki progenitorowe wątroby
EP1857542A4 (en) METHOD FOR IN VITRO AMPLIFICATION OF ADULT STEM CELLS
WO2010017562A3 (en) Induced pluripotent stem cells
WO2011043591A3 (en) Method for differentiation into retinal cells from stem cells
EP1302536A3 (en) Embryonic stem cells and neural progenitor cells derived therefrom
WO2009021151A8 (en) Isolation, characterization and propagation of germline stem cells
WO2011043592A3 (en) Compositions for inducing differentiation into retinal cells from retinal progenitor cells or inducing proliferation of retinal cells comprising wnt signaling pathway activators
WO2006047743A3 (en) Swine multipotent adult progenitor cells
RU2665364C2 (ru) Улучшение органов для трансплантации
WO2007051625A3 (en) Compositions and methods for producing pluripotent cells from adult testis
Bilodeau et al. Limitations of recellularized biological scaffolds for human transplantation
Deng et al. Hepatic progenitor cell represents a transitioning cell population between liver epithelium and stroma
Maepa et al. Advances in generating liver cells from pluripotent stem cells as a tool for modeling liver diseases
WO2006045105A3 (en) Generation and differentiation of adult stem cell lines
WO2007056505A3 (en) Systems and methods for selection and maintenance of homogeneous and pluripotent human embryonic stem cells
WO2012075462A3 (en) Methods and compositions for treatment of muscular dystrophy
WO2013184193A3 (en) Cancer stem cells and methods of using the same
Chen et al. Regulation of heme oxygenase 1 expression by miR-27b with stem cell therapy for liver regeneration in rats
Lee et al. Advances in liver organoids: model systems for liver disease
WO2005094162A3 (en) Culture and use of cells that secrete liver secretory factors
WO2006105204A3 (en) Compositions and their uses directed to thymus and activation-regulated chemokine (tarc)